SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001144204-14-006648
Filing Date
2014-02-07
Accepted
2014-02-06 18:50:49
Documents
1
Group Members
DAVID L. DOUGLASSDEEPIKA R. PAKIANATHAN, PH.D.DELPHI BIOINVESTMENTS VIII, L.P.DELPHI MANAGEMENT PARTNERS VIII, L.L.C.DOUGLAS A. ROEDERJAMES J. BOCHNOWSKI

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G v367031_sc13g.htm SC 13G 160733
  Complete submission text file 0001144204-14-006648.txt   162470
Mailing Address 800 CHESAPEAKE DRIVE REDWOOD CITY CA 94063
Business Address 800 CHESAPEAKE DRIVE REDWOOD CITY CA 94063 650-995-8200
OncoMed Pharmaceuticals Inc (Subject) CIK: 0001302573 (see all company filings)

IRS No.: 383572512 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-87757 | Film No.: 14581417
SIC: 2834 Pharmaceutical Preparations

Mailing Address 3000 SAND HILL ROAD BUILDING 1, SUITE 135 MENLO PARK CA 94025
Business Address 3000 SAND HILL ROAD BUILDING 1, SUITE 135 MENLO PARK CA 94025 650-854-9657
DELPHI VENTURES VIII LP (Filed by) CIK: 0001436285 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: SC 13G